Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 06 crawled time : 15:20 save search
Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
GNMSF | $291.12 3.83% 300
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | $29.51 0.85% 0.85% 500K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
Cisco Unveils Innovations Driving New Security Cloud Strategy
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
CSCO | $48.24 -0.52% -0.52% 20M
|
Technology Services
|
| O: 0.78%
H: 1.07%
C: -0.6%
security cloud
FDA APPROVES RIABNI™ (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN® (RITUXIMAB), FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
BGNE S | $138.39 -2.06% -2.1% 230K
|
Health Technology
|
| O: 7.48%
H: 0.45%
C: -4.8%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.2%
C: -1.16%
rituxan fda biosimilar
Gibbs Gardens: A 376-Acre Summer Bouquet with Blooms in Every Direction
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
FNCTF | $11.128 -20.84% 580
|
Communications
|
| O: 0.17%
H: 0.0%
C: 0.0%
PEGA Investors Have Opportunity to Lead Pegasystems Inc. Securities Fraud Lawsuit
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
PEGA | $58.5 -3.13% -3.23% 280K
|
Technology Services
|
| O: -0.41%
H: 0.94%
C: -1.14%
AXSM Investors Have Opportunity to Lead Axsome Therapeutics, Inc. Securities Fraud Lawsuit
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
AXSM | $68.26 -1.29% -1.3% 430K
|
Health Technology
|
| O: 2.74%
H: 0.72%
C: -0.99%
OSCR Investors Have Opportunity to Lead Oscar Health, Inc. Securities Fraud Lawsuit
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
OSCR | $14.8 0.41% 0.0% 2.8M
|
|
| O: 3.05%
H: 4.54%
C: -1.97%
NTRA | $90.42 -4.29% -4.48% 1.2M
|
Health Services
|
| O: 1.5%
H: 0.0%
C: 0.0%
Final Data From Phase 3 ASCENT Study Demonstrates Trodelvy Extends Overall Survival Over Chemotherapy in Second-Line Metastatic TNBC
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: -1.24%
H: 0.71%
C: -0.87%
trodelvy phase 3
Four Seasons Arrives in Venice: Luxury Hotel Brand to Expand Italian Portfolio with the Iconic Hotel Danieli
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
ARVL | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.58%
H: 0.0%
C: 0.0%
hotel
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.12%
H: 0.56%
C: -0.32%
deadline
SOPHiA GENETICS Provides an Update on its DEEP-Lung-IV Multimodal Clinical Study at ASCO 2022
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
SOPH | $4.85 -3.0% -3.09% 58K
|
|
| O: 3.51%
H: 3.52%
C: -8.36%
asco
Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - globenewswire.com
GNMSF | $291.12 3.83% 300
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | $29.51 0.85% 0.85% 500K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
MusclePharm Announces Private Placement of $2.5 Million Senior Secured Notes
Published: 2022-06-06 (Crawled : 15:20) - globenewswire.com
MSLP | $0.0002
|
Manufacturing
|
| O: 27.38%
H: 0.0%
C: -21.5%
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.